Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
RespireRx Pharmaceuticals (RSPI)
OTHER OTC:RSPI
RespireRx Pharmaceuticals (RSPI) Stock Price & Analysis
17 Followers
RSPI Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range― - ―
Previous Close$0.01
Volume1.18M
Average Volume (3M)N/A
Market Cap
$292.33K
Enterprise Value$345.50K
Total Cash (Recent Filing)$7.32K
Total Debt (Recent Filing)$60.48K
Price to Earnings (P/E)-0.7
Beta0.22
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding365,418,647
10 Day Avg. Volume3,964,182
30 Day Avg. VolumeN/A
Standard Deviation1.49
R-Squared0.00124
Alpha0.13
Financial Highlights & Ratios
Price to Book (P/B)-0.02
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit1.02
Enterprise Value/Ebitda-2.10
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
RespireRx Pharmaceuticals News
Ownership Overview
0.04%
Insiders
0.00%
Mutual Funds
0.00% Other Institutional Investors
99.96% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
RSPI FAQ
What was RespireRx Pharmaceuticals’s price range in the past 12 months?
Currently, no data Available
What is RespireRx Pharmaceuticals’s market cap?
Currently, no data Available
When is RespireRx Pharmaceuticals’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were RespireRx Pharmaceuticals’s earnings last quarter?
Currently, no data Available
Is RespireRx Pharmaceuticals overvalued?
According to Wall Street analysts RespireRx Pharmaceuticals’s price is currently Overvalued.
Does RespireRx Pharmaceuticals pay dividends?
RespireRx Pharmaceuticals does not currently pay dividends.
What is RespireRx Pharmaceuticals’s EPS estimate?
RespireRx Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does RespireRx Pharmaceuticals have?
RespireRx Pharmaceuticals has 365,418,640 shares outstanding.
What happened to RespireRx Pharmaceuticals’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of RespireRx Pharmaceuticals?
Currently, no hedge funds are holding shares in RSPI
---
Company Description
RespireRx Pharmaceuticals
RespireRx Pharmaceuticals, Inc. engages in the discovery, development and commercialization of innovative pharmaceuticals for the treatment of neurological and psychiatric disorders. The company was founded by Carl W. Cotman, Wayne Pambianchi and Gary S. Lynch on February 10, 1987 and is headquartered in Glen Rock, NJ.
---
---